PTGS2 and hepatocellular carcinoma: These results obtained in vivo were in agreement with the findings in vitro, suggesting that deacetylation of mito-COX-2 exerted selective PTM toward mitochondrial protein quality control (MPQC), which was a potential target to achieve HCC cell-growth inhibition.